Human suppressor trna oligonucleotides and methods of use for same
CA 2318374 C · Owner: Human Gene Therapy Research Institute · Inventors: Link, Charles J. Jr.; Panchal, Rekha G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel synthetic suppressor tRNA have been provided which provide read-through of internal nonsense mutations, or which can site-specifically alter translation of transcribed sequences. Uses of the same are also provided in genetic engineering protocols including gene therapy treatment of diseases such as Xeroderma pigmentosum.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 13, 1999 and granted September 4, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 13, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 13, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.